Fda approval of lexapro

Food and Drug Administration (FDA) for the treatment of adults and children over 12 years of age with major depressive disorder (MDD) or generalized anxiety disorder (GAD). Escitalopram, also known by the brand names Lexapro and Cipralex among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Escitalopram is the (S)-stereoisomer (Left-enantiomer) of the earlier Lundbeck drug citalopram, hence the name escitalopram. Whether escitalopram exhibits superior therapeutic properties to citalopram or merely represents an example of "evergreening" is controversial.

Fda approval of lexapro

Fda approval of lexapro

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Modernizr=function(a,b,c){function C(a)function D(a,b)function E(a,b)function F(a,b)function G(a,b)function H(a,b,d)function I(a,b,c)function J(),s.svg=function(),s.inlinesvg=function();for(var K in s)B(s, K)&&(x=Lower Case(),e[x]=s[K](),v.push((e[x]?

  • HERBAL REPLACEMENTS FOR EFFEXOR
  • COLCHICINE NOT ALWAYS CAUSE DIARRHEA
  • BUY CLOMID AND METFORMIN
  • Furosemide kidney damage
  • Aura soma 38

  • Lexapro is one of the most widely prescribed psychiatric medications in the U.


    Fda approval of lexapro

    Fda approval of lexapro

    Fda approval of lexapro

    Anyone considering the use of Lexapro or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. In order to use Medscape, your browser must be set to accept cookies delivered by the Medscape site.

    Fda approval of lexapro

    This content has not been reviewed within the past year and may not represent Web MD's most up-to-date information. WILL TRAZODONE CAUSE HAIR LOSS


    Fda approval of lexapro:

    Rating: 94 / 100

    Overall: 96 Rates
  • Добавить комментарий

    Ваш e-mail не будет опубликован. Обязательные поля помечены *